How many patents does
Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts have?
patents
1,810
families
334
granted
356
applications
1,454
EP
451
US
375
WO
294
JP
84
CN
58
KR
17
GB
1
RoW
530
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts
Top ten assignees appearing on patents
2009 - 2018
| bayer pharma | 44 |
| medigene | 40 |
| precisis | 15 |
| apogenix | 10 |
| roche | 7 |
| fidia farmaceutici | 7 |
| heidelberg immuno therapeutics | 7 |
| boehringer ingelheim international | 7 |
| electrophoretics | 5 |
| metecon | 3 |
2018
| bayer pharma | 11 |
| medigene | 11 |
| electrophoretics | 2 |
| bayer | 2 |
Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| treatment of tumors using specific anti-l1 antibody | 36 | 2007 |
| benzimidazol-2-amines as midh1 inhibitors | 29 | 2014 |
| amatoxin-armed therapeutic cell surface binding components designed for tumour therapy | 29 | 2009 |
| labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging ag… 🛈 | 26 | 2013 |
| compositions for diagnosis and therapy of diseases associated with aberrant expression o… 🛈 | 23 | 2003 |
| rspondins as modulators of angiogenesis and vasculogenesis | 23 | 2006 |
| neutralization of cd95 activity blocks invasion of glioblastoma cells in vivo | 22 | 2006 |
| verfahren zum screening einer substanz zur modulierung der wnt -signalkaskade. | 21 | 2002 |
| parvovirus cancer therapy and combination with chemotherapy | 20 | 2007 |
| means and methods for treating or diagnosing idh1 r132h mutant-positive cancers | 20 | 2012 |